T1	p 65 82	abdominal surgery
T2	p 177 276	patients who underwent hysterectomy . METHODS Forty patients were divided into four groups of ten .
T3	p 440 471	ten patients served as controls
T4	i 6 26	Intrathecal morphine
T5	i 108 116	morphine
T6	i 200 212	hysterectomy
T7	i 297 378	intrathecal 0.5 mg morphine ( Group IT0.5 ) , intrathecal 0.1 mg morphine ( Group
T8	i 390 410	10 mg morphine i.v .
T9	i 485 526	inhalation anesthesia alone ( Group C ) .
T10	i 677 685	chromium
T11	i 1519 1530	intrathecal
T12	i 1538 1546	morphine
T13	o 18 54	morphine suppresses NK cell activity
T14	o 120 155	natural killer ( NK ) cell activity
T15	o 646 674	blood NK cell activity using
T16	o 677 693	chromium release
T17	o 729 818	plasma catecholamines and cortisol levels . The postoperative pain score and side effects
T18	o 882 898	NK cell activity
T19	o 912 925	postoperative
T20	o 1082 1100	NK cell activities
T21	o 1162 1220	plasma adrenaline nor noradrenaline concentrations changed
T22	o 1248 1270	plasma cortisol levels
T23	o 1329 1343	The pain score
T24	o 1498 1515	analgesic effects
T25	o 1560 1575	immune response